Nesuparib
- Generic Name
- Nesuparib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H24N6O
- CAS Number
- 2055357-64-5
- Unique Ingredient Identifier
- U6N7333GDW
- Associated Conditions
- -
- Associated Therapies
- -
First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-16
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 92
- Registration Number
- NCT06502743
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath